Apply current policy criteria
Connect codes, payer policy, documentation, and cited criteria before work moves forward.
Explore policy intelligenceChat with GenHealth to automate any coding or chart task.
82600 is a CPT4 code for Cyanide. Coverage and prior authorization can vary by payer, plan, diagnosis, place of service, and documentation, so teams should connect the code to the current payer policy before acting.
Connect codes, payer policy, documentation, and cited criteria before work moves forward.
Explore policy intelligenceTurn requirements into intake, submission, status checks, and follow-up across existing systems.
See prior auth automationAutomate billing, denials, posting, and A/R work without adding another queue for your team.
See RCM automationThis page is an operational reference, not medical or legal advice. Payer requirements change; verify current plan rules and patient-specific facts.
Cyanide Treatment (Hydroxocobalamin Therapy)
Cyanide treatment involves administering hydroxocobalamin, a form of vitamin B12, to counteract cyanide poisoning. This procedure is crucial in emergency settings where cyanide exposure is suspected, such as in industrial accidents or smoke inhalation from fires.
Condition Addressed: Acute cyanide poisoning. Goals and Outcomes: The goal is to rapidly neutralize cyanide in the bloodstream, preventing it from disrupting cellular respiration. Success is marked by the stabilization of the patient's vital signs and reversal of symptoms.
Symptoms: Sudden headache, confusion, seizure, respiratory distress, and cardiovascular collapse. Patient Criteria: Suspected or confirmed cyanide exposure, particularly in settings involving smoke inhalation or industrial chemicals.
Pre-procedure Instructions: This is an emergency procedure, so no preparation from the patient is typically required. Diagnostics: Blood samples may be taken to confirm cyanide levels, but treatment should not be delayed while waiting for results.
Tools and Equipment: Intravenous catheter, hydroxocobalamin infusion kit, monitoring equipment for vital signs. Anesthesia/Sedation: Not typically required unless the patient needs intubation for airway protection.
The procedure takes approximately 15-30 minutes for the initial infusion, with additional time for supportive care as required.
Typically performed in emergency rooms, intensive care units, or areas designated for emergency medical response.
Emergency physicians, critical care nurses, and paramedics may be involved. If necessary, an anesthesiologist may provide airway management.
Hydroxocobalamin can rapidly neutralize cyanide, reversing its toxic effects and stabilizing the patient. The beneficial effects are often seen within minutes to hours.
Post-Procedure Care: Ongoing monitoring in an ICU is common. Patients may need additional supportive care, including oxygen and fluids. Recovery Time: Varies based on severity but often improves within hours to days. Close follow-up is essential to monitor for any late-onset complications.
During treatment, patients may experience temporary skin redness and urine discoloration. Prompt pain management and comfort measures are provided, including oxygen and supportive care to alleviate symptoms of poisoning.
See how GenHealth connects policy review to documentation, prior authorization, billing, and follow-up across the systems your team already uses.